Enanta Pharma (ENTA) Tops Q4 EPS by 5c

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
• Estee Lauder (EL) Tops Q4 EPS by 7c, Beats on Revenue